Hyperpigmentation refers to darkening or discoloration of the skin due to higher levels of melanin than normal. Hyperpigmentation can be caused by inflammation, sun damage, or other skin injuries, including those related to acne vulgaris. People with darker skin tones are more susceptible to hyperpigmentation, especially with excess sun exposure. Hyperpigmentation disorders include post-inflammatory hyperpigmentation (PIH), melasma, and sun lentigines. Sun damage, also called sun lentigines, is a major cause of hyperpigmentation which occurs due to continuous exposure to harmful ultra violet rays from sun and causes small dark spots on the skin. Hormonal change due to pregnancy, excessive estrogen production, and use of birth control pill can also cause hyperpigmentation. It is called melasma, which is chronic and relapsing. Post inflammatory hyperpigmentation is caused due to skin conditions such as injury, acne, trauma & burn, and post-surgery spots.
Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56124
The global hyperpigmentation treatment devices market is projected to grow at a rapid pace during the forecast period. Rise in prevalence of hyperpigmentation disorders leads to an increase in the number of people undergoing diagnosis in the form of topical drugs or laser and treatment using techniques such as microdermabrasion and light therapy. This, in turn, is expected to increase the uptake of hyperpigmentation disorder drugs and procedures, thereby driving the global hyperpigmentation treatment devices market. Additionally, adoption of laser-based devices is increasing due to widening utility of laser devices. Laser-based devices are used to treat skin photo damage, hyperpigmentation, removal of unwanted hair, acne, wrinkles, tattoo removal, facial vein removal, and body contouring. Moreover, rise in prevalence of skin-related problems such as acne, sun damaged skin, scars, and stretch marks increases the utilization of minimally invasive, non-surgical, device-based skin resurfacing procedures. This is likely to boost the growth of the global hyperpigmentation treatment devices market. However, risk of post inflammatory hyperpigmentation due to the use of laser and light-based devices and lack of reimbursement by insurance companies for skin resurfacing procedures restrain the global market.
Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=56124
The global hyperpigmentation treatment devices market can be segmented based on, product type, end-user, and region. In terms of product type, the hyperpigmentation treatment devices market can be bifurcated into single roller pump and double roller pump. Based on end-user, the global hyperpigmentation treatment devices market can be divided into hospitals and ambulatory surgical centers.
In terms of region, the global hyperpigmentation treatment devices market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region can be divided into specific countries/sub-regions such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC Countries. North America dominated the global hyperpigmentation treatment devices market in 2017 because of increase in the geriatric population resulting in high demand for skin resurfacing and removal of dark spots from hyperpigmentation in the U.S. According to American Society for Plastic Surgeons’ Plastic Surgery Statistics report, photo rejuvenation, also known as intense pulse light (IPL) therapy, is the fourth most popular non-invasive cosmetic procedure for skin resurfacing (includes hyperpigmentation) in the U.S., with around 667,561 procedures performed in 2017. Asia Pacific is expected to be a highly attractive hyperpigmentation treatment devices market during the forecast period due to increase in health care awareness and rise in demand for advanced medical technology.
Pre Book A Report at @ https://www.transparencymarketresearch.com/checkout.php?rep_id=56124<ype=S
Key players operating in the global hyperpigmentation treatment devices market are Cutera, Inc., Hologic, Inc., Syneron Medical Ltd., Lutronic Corporation, Lumenis Ltd., AMI, Strata Skin Sciences, Inc., Alma Lasers, Ltd., BISON MEDICAL, Solta Medical, Inc., EL.En. S.p.A., Sciton, Inc., Lynton Lasers Ltd., and Fotona d.o.o., among others. These players have adopted strategies such as collaborations, agreements, partnerships, and new product launches to gain a competitive advantage in the market.
More Trending Reports by Transparency Market Research
- https://www.prnewswire.com/news-releases/new-engineering-approaches-in-vascular-grafts-market-expands-horizon-of-endovascular-surgeries-synthetic-products-attract-rd-tmr-301278115.html
- https://www.prnewswire.com/news-releases/technological-advancements-like-3d-printing-and-an-increase-in-the-number-of-amputations-due-to-various-factors-will-serve-as-growth-pillars-for-the-prosthetics-market-says-tmr-301271549.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Many people suffer from hyperpigmentation, often known as skin pigmentation.
It is one of the most common causes of face wrinkles and dark under-eye circles.
This might be due to hereditary causes, skin damage, hormone imbalance, excessive sun exposure, medicine, or even a bad diet.
An intriguing discovery was that nearly half of the individuals suggested intrusive techniques to cure their skin concerns.According to the report, the use of non-invasive techniques has grown in popularity in recent years.
Melasma is caused by the body's failure to generate an appropriate quantity of melanin, the pigment that gives skin color.
The plasma begins to develop in dark patches on the skin over time, causing unattractive skin discoloration and uneven pigmentation.There are two treatments that can be performed to treat hyperpigmentation induced by melanism.
Hyperpigmentation Disorders Treatment Market: Information by Treatment Type (Topical Drugs, Chemical Peels, and Laser Therapy), by Disease Indication (Melasma, Solar and Lentigines), by End-User (Hospitals and Others) — Global Forecast till 2023The Hyperpigmentation Disorders Treatment Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportMajor Key PlayersThe key strategies followed by the players operating in the global Hyperpigmentation Disorders Treatment Market were innovation, product development, acquisition, and expansion.Allergan, Inc., Bayer AG, EpiPharm AG, Episciences, Inc., Galderma laboratories (Nestle Skin Health S.A), Obagi Cosmeceuticals LLC, Pierre Fabre, RXi Pharmaceuticals Corporation, SkinCeuticals International, and Vivier Pharma.
Market Segment AnalysisGlobal Hyperpigmentation Disorders Treatment Market, by Treatment TypeTopical DrugsChemical PeelsMicrodermabrasionLaser TherapyPhototherapyOthersGlobal Hyperpigmentation Disorders Treatment Market, by Disease IndicationMelasmaSolar LentiginesPost-inflammatory HyperpigmentationSynchrocyclotronsOthersGlobal Hyperpigmentation Disorders Treatment Market, by End-UserHospitalsAesthetic Clinics & Dermatology CentersOthers Top of FormKey Study Highlights:This report for Hyperpigmentation Disorders Treatment Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report also gives a broad study of the different market segments and regions.Regional AnalysisGeographically, the global Hyperpigmentation Disorders Treatment Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462Chapter 9.
Global Hyperpigmentation Disorders Treatment Market By Region9.1 Introduction9.2 America9.2.1 North America9.2.1.1 U.S.9.2.1.2 Canada9.2.2 South America9.3 Europe9.3.1 Western Europe9.3.1.1 Germany9.3.1.2 France9.3.1.3 Italy9.3.1.4 Spain9.3.1.5 U.K.9.3.1.6 Rest Of Western Europe9.3.2 Eastern Europe9.4 Asia Pacific9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 Republic Of Korea9.4.6 Rest Of Asia Pacific9.5 The Middle East & Africa9.5.1 United Arab Emirates9.5.2 Saudi Arabia9.5.3 Oman9.5.4 Kuwait9.5.5 Qatar9.5.6 Rest Of The Middle East & AfricaAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
Transparency Market Research (TMR) has published a new report titled ‘Hyperpigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global hyperpigmentation disorders treatment market was valued at US$ 3,947.3 Mn in 2017 and is projected to reach US$ 7,225.6 Mn by 2026, expanding at a CAGR of 7.2% during the forecast period from 2018 to 2026.
The report suggests that augmented adoption of lasers in hyperpigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, increase in prevalence of pigmentation related disorders, rise in awareness about skin rejuvenation, improving lifestyle, and increasing disposable income are likely to drive the hyperpigmentation disorders treatment market from 2018 to 2026.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=46644Despite its considerable patient population globally, the hyperpigmentation disorders treatment market has often been overlooked and has remained stagnant for the past few decades, with no novel drugs entering the arena.
The lack of dedicated research programs has been attributed to pharmaceutical companies viewing topicals, the mainstay of hyperpigmentation disorders treatment therapy, as being inexpensive with a poor return on investment.
Instead, the market has shifted towards reformulations of existing products and/or fixed-dose combination therapies.
Examples of the latter include combination products by key dermatology players, such as Galderma’s Tri-Luma (fluocinolone acetonide/hydroquinone/tretinoin).TOC of Report – https://www.transparencymarketresearch.com/report-toc/46644 Innovative products in hyperpigmentation disorders should focus on cost-effectiveness, potential to improve compliance.
Historically, pharmaceutical companies have been reluctant to enter the hyperpigmentation disorders market due to the poor return on investment in this competitive landscape.
